Fig. 5From: Effects of dapagliflozin in the progression of atherosclerosis in patients with type 2 diabetes: a meta-analysis of randomized controlled trialsImpact of dapagliflozin on HDL-C changes relative to baseline after deleting Fadini 2017 and Nur Aisyah 2020Back to article page